Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …

Background and Objectives To evaluate the long-term safety and efficacy of tocilizumab
(TCZ), a humanized anti–interleukin-6 receptor antibody in myelin oligodendrocyte …

Neuromyelitis optica spectrum disorder (NMOSD) is a rare inflammatory CNS disease that
primarily manifests as relapsing episodes of severe optic neuritis and myelitis. Diagnosis of …

Myelin oligodendrocyte glycoprotein (MOG)-associated disease (MOGAD) is a rare,
antibody-mediated inflammatory demyelinating disorder of the central nervous system …

Importance Recent studies suggest that maintenance intravenous immunoglobulin (IVIG)
may be an effective treatment to prevent relapses in myelin oligodendrocyte glycoprotein …

Background and Objectives Rituximab is used widely for relapse prevention in neuromyelitis
optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein (MOG)-IgG …

Background Optic neuritis (ON) is the most common manifestation of myelin oligodendrocyte
glycoprotein antibody associated disorder (MOGAD) and multiple sclerosis (MS). Acute ON …

New diagnostic criteria for myelin oligodendrocyte glycoprotein antibody-associated disease
(MOGAD) have recently been proposed, distinguishing this syndrome from other …

In recent years, the understanding about the different clinical phenotypes, diagnostic and
prognostic factors of myelin oligodendrocyte glycoprotein-antibody-associated disorders …